LASH, Timothy L. et al. Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncologica, [S. l.], v. 49, n. 3, p. 305–312, 2010. DOI: 10.3109/02841860903575273. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/32554. Acesso em: 29 apr. 2026.